This is the type of chart that will grab the attention of momentum traders.
Pfizer is a quality dividend stock that's now trading at a discount.
RedHill Biopharma has adopted 'Veeva Vault CDMS', Veeva's modern cloud platform.
Fresh off IPO, company sees mushrooming opportunity in psilocybin.
Let's dig into Strongbridge Biopharma and Agenus.
2021 will be a big year, upside is at least twice the current valuation, and downside is limited to 10% from current levels.
The euphoria in biotech stocks Monday was a nice change of pace. It also brought to the forefront some lessons about M&A in this industry.
Stocks are reasonable. Or even cheap. There will be more sell-offs ahead but remember this day and do not get too negative.
Stick to themes like biotechnology, SPACs, EV batteries, and others.
We've become accustomed lately to gap-up opens on Mondays, but some fresh acquisition agreements are helping drive this Monday's action.